Joris Vanderlocht
InvestorPartner and Chief Scientific Officer at Bioqube Ventures
Houthalen, Flemish Region, Belgium
About
Joris Vanderlocht is Partner and CSO at Bioqube Ventures, joining in 2018 with over 15 years in academic and translational immunology covering cancer immunotherapy, autoimmunity, and immune deficiencies. He leads scientific diligence, supports portfolio companies and venture creation, and drives translational research toward early clinical development.
Contact· self-published, not guessed
Invests in
BiotechMedical Devices
Experience
- Bioqube VenturesPartner and CSOcurrent2025 — presentHasselt, Flemish Region, Belgium
- Bioqube VenturesChief scientific advisor2022 — 2025Mechelen, Flemish Region, Belgium
- Bioqube VenturesSenior Business Analyst2018 — 2022Beerse, Belgium
- Stealth NewCoBoard directorcurrent2025 — present
- Commit BiologicsBoard Observer2021 — 2024
- Primmune TherapeuticsBoard Observer2020 — 2024
- Spica TherapeuticsBoard Observer2021 — 2023
- UHasseltResearch Scientist2018 — 2022Hasselt, Belgium
- Maastricht UMC+Laboratory specialist Medical Immunology at the Central Diagnostic Laboratory2017 — 2018Maastricht Area, Netherlands
- Maastricht university medical centerStafmember Tissue Typing and Transplantation Immunology2011 — 2017Maastricht Area, Netherlands
- Maastricht university medical centerPostdoctoral researcher2006 — 2011
- Fred HutchResident in transplantation immunology2015Greater Seattle Area
- UCLA Department of Microbiology, Immunology and Molecular GeneticsResident in Transplantation Immunology2014Los Angeles
- Hasselt UniversityPhD student2001 — 2006
Skills & more
pre-clinical development1Oncology1Biotechnology1Flow Cytometry8tissue typingMolecular & Cellular BiologyImmunology12Immunohistochemistry4Cell Culture4Molecular Biology6Cell Biology5Lifesciences
+12 more
ELISAStem CellsPCRqPCRScienceGeneticsFACSBiochemistryCancerDNADNA sequencingGenomicsLanguages English · French
From Joris's professional profile.
Colleagues at Bioqube Ventures
Alexander Demoulin
Associate at Bioqube Ventures
Clement Salque
Associate at Bioqube Ventures
Debora Dumont
Managing Partner at Bioqube Ventures
Dirk Reyn
Managing Partner at Bioqube Ventures
Geert Tackaert
Finance Director at Bioqube Ventures
Jacques Mizrahi
Venture Partner at Bioqube Ventures
Janine Schuurman
Senior Advisor at Bioqube Ventures
Jon Edwards
Managing Partner at Bioqube Ventures
Frequently asked questions
- Who is Joris Vanderlocht?
- Joris Vanderlocht is Partner and CSO at Bioqube Ventures, joining in 2018 with over 15 years in academic and translational immunology covering cancer immunotherapy, autoimmunity, and immune deficiencies. He leads scientific diligence, supports portfolio companies and venture creation, and drives translational research toward early clinical development.
- Where does Joris Vanderlocht work?
- Joris Vanderlocht is Partner and Chief Scientific Officer at Bioqube Ventures.
- What does Joris Vanderlocht invest in?
- Joris Vanderlocht invests in Biotech, Medical Devices.
- Where did Joris Vanderlocht go to school?
- Joris Vanderlocht studied at Convent medische immunologie (CMI), The Netherlands (Medical immunologist); SMBWO, The Netherlands (SMBWO certified Immunologist); Hasselt University (PhD, Immunology).
Same school
Also attended Hasselt University12
Katleen VandersmissenManaging Partner at Heran PartnersReginald VossenBestuurder - Voorzitter at AngelwiseHarry De SmedtIC at AngelwiseLudwig GorisPartner at Capricorn Venture PartnersPhilippe QueveauCEO at CITA InvestissementAndy RiceInvestment Director at Bestport Private Equity
+ 6 more
Shared employers
Also worked at Bioqube Ventures14
Debora DumontManaging Partner at Bioqube VenturesDirk ReynManaging Partner at Bioqube VenturesNico VandervelpenManaging Partner at Bioqube VenturesJoris De MaeyerExecutive in Residence at Bioqube VenturesAlexander DemoulinAssociate at Bioqube VenturesRoderick VerhelstPrincipal at Bioqube Ventures
+ 8 more
